For the quarter ending 2026-03-31, MRK has $128,685M in assets. $5,327M in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 5,327 | 14,565 | 18,169 | 8,007 |
| Short-term investments | 375 | 0 | 45 | 615 |
| Accounts receivable (net of allowance for doubtful accounts of 103 in 2026 and 97 in 2025) | 12,210 | 11,775 | 12,120 | 11,846 |
| Inventories (excludes inventories of 6,195 in 2026 and 5,681 in 2025 classified in other assets - see note6) | 6,479 | 6,658 | 6,444 | 6,601 |
| Other current assets | 10,624 | 10,518 | 10,779 | 9,996 |
| Total current assets | 35,015 | 43,516 | 47,557 | 37,065 |
| Investments | 1,105 | 956 | 1,117 | 774 |
| Land | - | 321 | - | - |
| Buildings | - | 17,983 | - | - |
| Machinery, equipment and office furnishings | - | 19,760 | - | - |
| Construction in progress | - | 9,166 | - | - |
| Property, plant and equipment (at cost) | - | 47,230 | - | - |
| Less accumulated depreciation | - | 21,914 | - | - |
| Property, plant and equipment, at cost, net of accumulated depreciation of 22,288 in 2026 and 21,914 in 2025 | 25,433 | 25,316 | 25,639 | 25,236 |
| Goodwill | 21,581 | 21,579 | 21,587 | 21,591 |
| Finite-lived intangible assets, gross carrying amount-Developed Technology Rights | - | 42,038 | - | - |
| Indefinite-lived intangible assets-In Process Research And Development | - | 427 | - | - |
| Finite-lived intangible assets, gross carrying amount-Trade Names | - | 2,881 | - | - |
| Finite-lived intangible assets, gross carrying amount-Licenses And Other | - | 10,064 | - | - |
| Intangible assets, gross carrying amount | - | 55,410 | - | - |
| Accumulated amortization | - | 28,729 | - | - |
| Other intangibles, net | 25,745 | 26,681 | 15,313 | 15,193 |
| Other assets | 19,806 | 18,818 | 18,333 | 17,664 |
| Total assets | 128,685 | 136,866 | 129,546 | 117,523 |
| Loans payable and current portion of long-term debt | 2,444 | 2,589 | 1,405 | 1,434 |
| Trade accounts payable | 3,863 | 4,404 | 4,147 | 3,892 |
| Accrued and other current liabilities | 14,549 | 14,468 | 16,186 | 14,502 |
| Income taxes payable | 3,946 | 4,726 | 4,848 | 4,156 |
| Dividends payable | 2,143 | 2,140 | 2,042 | 2,053 |
| Total current liabilities | 26,945 | 28,327 | 28,628 | 26,037 |
| Long-term debt | 46,673 | 46,750 | 39,969 | 33,968 |
| Deferred income taxes | 1,494 | 1,439 | 1,381 | 1,427 |
| Other noncurrent liabilities | 7,642 | 7,688 | 7,661 | 7,031 |
| Common stock, 0.50 par value authorized - 6,500,000,000 shares issued - 3,577,103,522 shares in 2026 and 2025 | 1,788 | 1,788 | 1,788 | 1,788 |
| Other paid-in capital | 45,176 | 45,029 | 44,832 | 44,644 |
| Retained earnings | 66,721 | 73,075 | 72,231 | 68,477 |
| Accumulated other comprehensive loss | -4,060 | -4,287 | -5,202 | -5,421 |
| Stockholders' equity before deduction for treasury stock | 109,625 | 115,605 | 113,649 | 109,488 |
| Less treasury stock, at cost 1,107,410,143 shares in 2026 and 1,102,476,756 shares in 2025 | 63,747 | 62,999 | 61,799 | 60,495 |
| Total merck& co., inc. stockholders equity | 45,878 | 52,606 | 51,850 | 48,993 |
| Noncontrolling interests | 53 | 56 | 57 | 67 |
| Total equity | 45,931 | 52,662 | 51,907 | 49,060 |
| Liabilities and equity | 128,685 | 136,866 | 129,546 | 117,523 |
Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK)